Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Ferrol (43)

2024

  1. Surgery for inflammatory bowel disease in Spain: How are we doing? Initial results of a nationwide prospective registry

    Cirugia Espanola, Vol. 102, Núm. 7, pp. 355-363

2023

  1. Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohort.

    Multiple Sclerosis and Related Disorders, Vol. 75

  2. Falls Predict Acute Hospitalization in Parkinson's Disease

    Journal of Parkinson's disease, Vol. 13, Núm. 1, pp. 105-124

2022

  1. The EPICTER score: a bedside and easy tool to predict mortality at 6 months in acute heart failure

    ESC Heart Failure, Vol. 9, Núm. 4, pp. 2348-2356

2021

  1. Differences in the clinical profile and management of atrial fibrillation according to gender. Results of the registro gallego intercéntrico de fibrilación auricular (regueifa) trial

    Journal of Clinical Medicine, Vol. 10, Núm. 17

  2. Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain

    BMC Cancer, Vol. 21, Núm. 1

  3. Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study

    Medicina Intensiva, Vol. 45, Núm. 6, pp. 332-346

  4. Rationale, design and basal characteristics of REGUEIFA study (Multicenter Registry of Atrial Fibrillation in Galicia)

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 197-207

2020

  1. Antimicrobial susceptibility of Escherichia coli producers of community urinary tract infections in Galicia (Spain). Period: 2016-2017

    Atencion Primaria, Vol. 52, Núm. 7, pp. 462-468

  2. Impact of a Home Telehealth Program After a Hospitalized COPD Exacerbation: A Propensity Score Analysis

    Archivos de Bronconeumologia

2019

  1. Diverse large HIV-1 non-subtype B clusters are spreading among men who have sex with men in Spain

    Frontiers in Microbiology, Vol. 10, Núm. APR

  2. Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers

    Cancer Medicine, Vol. 8, Núm. 3, pp. 882-889

2018

  1. Alcohol consumption and lung cancer risk in never smokers: A pooled analysis of case-control studies

    European Journal of Public Health, Vol. 28, Núm. 3, pp. 521-527

  2. Real world data of nivolumab for previously treated non-small cell lung cancer patients: A Galician lung cancer group clinical experience

    Translational Lung Cancer Research, Vol. 7, Núm. 3, pp. 404-415

  3. Systemic Treatment of Moderate to Severe Psoriasis in Pediatric Patients in Galicia, Spain: A Descriptive Study

    Actas Dermo-Sifiliograficas, Vol. 109, Núm. 8, pp. 722-732

2017

  1. Environmental tobacco smoke exposure and EGFR and ALK alterations in never smokers' lung cancer. Results from the LCRINS study

    Cancer Letters, Vol. 411, pp. 130-135

2016

  1. Cut-offs and response criteria for the Hospital Universitario la Princesa Index (HUPI) and their comparison to widely-used indices of disease activity in rheumatoid arthritis

    PLoS ONE, Vol. 11, Núm. 9

  2. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

  3. Residential radon, EGFR mutations and ALK alterations in never-smoking lung cancer cases

    European Respiratory Journal, Vol. 48, Núm. 5, pp. 1462-1470

  4. Small cell lung cancer in never-smokers

    European Respiratory Journal, Vol. 47, Núm. 3, pp. 947-953